Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Fortune Brands Innovations Inc

YUM! Brands

Almost two years ago, I wrote about seven stocks to buy whose products and services were in high demand.  What made the story unique is that each company recommended had the word “Brands” as part of their corporate name.

3 Best Stocks to Buy for Investors Building a ‘Brands' Portfolio: 2023 Edition

Curaleaf Holdings, Inc.

Scotts Miracle-Gro

The U.S. Department of Health and Human Services recently called for cannabis to move from Schedule I (the most restrictive category) to Schedule III. While the transition hasn't taken effect yet, and rescheduling still falls short of decriminalization, a reclassification would have a major impact on U.S. cannabis stocks.

Rescheduling Marijuana 2023: 3 Cannabis Stocks That Could Skyrocket

Aurora Cannabis

Canopy Growth

After amazing gains Monday, two of these cannabis stocks dropped Tuesday morning -- while one continued to pop. New bills in Congress are adding confusion to the marijuana legalization picture.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks Are All Over the Map Today

Greenlane Holdings

High Tide

Marijuana stocks are the investment of the future for many reasons. For instance, the legal cannabis industry is still new and developing quickly. It was not long ago when the talks about legal cannabis were a bit taboo. Yet from 2018 to 2023 things have changed in favor of legal cannabis. There has been so much change that more people are interested in investing in cannabis. There has been a rise in the number of people who use legal cannabis. The more people who buy cannabis the better it is for the industry and the companies themselves.

3 Marijuana Stocks To Watch As The Cannabis Industry Continues To Grow

The world of investing and trading is abuzz with excitement as one sector theme has recently emerged as a blazing hot topic of discussion: cannabis stocks.

Cannabis Stocks: Green Gold Rush or Risk Off?

Aurora Cannabis is paying down debt -- and promising positive free cash flow (FCF) in 2024. Wall Street analysts don't think the company will be FCF-profitable before 2026.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All Exploded Higher Today

Cronos Group

Marijuana penny stocks and higher-priced cannabis stocks are having a moment in the stock market right now. Mainstream stock market news is about inflation being high, and considered a negative.

Marijuana Penny Stocks Are On Fire, 3 To Watch Right Now

When considering which cannabis stocks to buy, you may be tempted to go with Tilray Brands (NASDAQ: TLRY ). Tilray is a diversified company with four main segments: Cannabis, Distribution, Wellness and Beverage alcohol.

TLRY Outlook: How Tilray Fits in the Cannabis Stocks Puzzle

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cannabis companies.

Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging

The Department of Health and Human Services believes cannabis shouldn't be a Schedule I substance. Rescheduling marijuana could be an important first step in legalizing it.

This Government Agency Calls for Rescheduling Marijuana: Is It a Sign Marijuana Legalization Is Coming?

Best-Selling Redecan Brand Gets a Boost with New Limited-Edition Cannabis Flower Genetics and Product Lineup Best-Selling Redecan Brand Gets a Boost with New Limited-Edition Cannabis Flower Genetics and Product Lineup

Tilray Expands Market Leading Cannabis Portfolio With Launch of New Redecan Products Across Canada

AFC Gamma

Cannabis stocks may be some of the most controversial investing ideas. Yet, they could also become some of the most profitable.That reality may happen if cannabis can be rescheduled and federally legalized.

Investing in Cannabis Stocks? 3 Marijuana Companies That Could Get a Massive Rescheduling Boost

Village Farms International

We're glad you're here to learn about this week's top marijuana stocks, poised to see significant increases in September 2023. As the cannabis industry evolves, savvy investors seek opportunities while considering risk. This study combines technical analysis with lessons from the rapidly expanding cannabis industries in the United States and Canada.

Green Investments: Top Canadian Marijuana Stocks for September 2023

Cannabis stocks have floundered over the past several years. However, the momentum building within the global legalization movement has recently sparked a trend reversal.

3 Top Growth Stocks to Buy in September

Easterly Government Properties

Harte Hanks

Philip Morris

Constellation Brands

Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (DEA) to consider moving marijuana from Schedule I to Schedule III.

Why Are Cannabis Stocks Still Up Today?

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

SNDL Inc.

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: Is there more upside left?

Cannabis stocks are still a buy despite recent double-digit gains

Polestar Automotive Holding UK PLC

Riot Blockchain

When it comes to growth stocks, the rally can be ferocious. And while we are not in the euphoria of 2021 when stocks delivered multi-bagger returns in a matter of weeks, there are dozens of growth stocks that have surged over 100% in a matter of few months.

3 Growth Stocks That Can Double Before the End of 2023

Last month, the Department of Health and Human Services suggested easing regulations on marijuana use. The Drug Enforcement Agency has final say on that -- but its boss, President Joe Biden, now says he supports medical marijuana legalization.

Why Marijuana Stocks Keep Growing Higher Tuesday

OrganiGram Holdings Inc.

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

Tilray (NASDAQ: TLRY ) stock is climbing higher on Tuesday as investors continue to hold out hope for the decriminalization of marijuana. The excitement around decriminalization comes after a letter was sent to the DEA seeking to reduce it from a Schedule I to Schedule III drug.

Why Is Tilray (TLRY) Stock Up 7% Today?

Anheuser-Busch InBev

Tilray agreed to pay AB InBev $85 million in cash to acquire eight leading beer brands. The purchase will triple Tilray's beer business, making it the fifth-largest craft brewer in the U.S. It's a smart move to diversify as Tilray's core cannabis segment languishes in the near term.

Tilray Just Acquired 8 Big Beer Brands From Anheuser-Busch. Is the Stock About to Pop?

In a previous article, I discussed Tilray's acquisition of Truss Beverage a company that makes cannabis infused beverages. Cannabis producers like Tilray (NASDAQ: TLRY ) often raise investor caution due to their historical volatility.

Tilray's Cannabis Beverage Move: Is It Time to Buy, Hold or Sell?

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

Cannabis stocks set to end week on a high following marijuana rescheduling recommendation

Roundhill Cannabis ETF

When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.

Time to Get High on Pot Stocks? (3 Catalysts)

News for Tilray Brands Stock (TLRY)